InvestorsHub Logo
Followers 177
Posts 24473
Boards Moderated 12
Alias Born 04/03/2002

Re: jedijazz post# 496

Tuesday, 02/23/2021 9:43:26 AM

Tuesday, February 23, 2021 9:43:26 AM

Post# of 579
Big acquisition development for CBSC announced today which should move the company into a very strong position in the vital cardiac monitoring field. This is impressive.

Note the comments from the CEO:

Charles Martin, President and CEO of CB Scientific, Inc. stated, “The acquisition of Cardiolink Corporation fits perfectly into our strategic plan and efforts to positively impact outcomes for the more than 655,000 Americans who die from heart disease in the United States every year. Cardiovascular disease is the leading cause of death in the US, killing one in every four people every year, and costing the US more than $219B annually. The addition of this well-established, proven company, along with our existing and future products and services, will help to solidify CBSC's expanded service offering in our efforts to become a leader in the US Remote Patient Monitoring market. Timely and early detection of potential heart rhythm issues is the key to better diagnosis and improved outcomes, reducing cost and helping to improve quality of life for patients. We look forward to the positive effects that the addition Cardiolink's IDTF operation will have for our company.”